作者：
Fleischhauer,K. [1]
;
Shaw,B.E. [2]
;
Gooley,T. [3]
;
Malkki,M. [4]
;
Bardy,P. [5]
;
Bignon,J.-D. [6]
;
Dubois,V. [7]
;
Horowitz,M.M. [8]
;
Madrigal,J.A. [9]
;
Morishima,Y. [10]
;
Oudshoorn,M. [11]
;
Ringden,O. [12]
;
Spellman,S. [13]
;
Velardi,A. [14]
;
Zino,E. [15]
;
Petersdorf,E.W.
作者单位：
Division of Haematology and Clinical Immunology, University of Perugia, Perugia, Italy
[1]
Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden
[2]
Anthony Nolan Research Institute, Royal Free Hospital, London, United Kingdom
[3]
Aichi Cancer Center, Nagoya, Japan
[4]
Europdonor Foundation, Leiden, Netherlands
[5]
Transplant Services Laboratory, Australian Red Cross Blood Service, Melboune, VIC, Australia
[6]
HLA Laboratory, établissement Fran?ais du Sang, Nantes, France
[7]
Unit of Molecular and Functional Immunogenetics, Division of Regenerative Medicine, Stem Cells and
[8]
HLA Laboratory, établissement Fran?ais du Sang, Lyon, France
[9]
Aichi Cancer Center, Nagoya, Japan, Japan Marrow Donor Program, Tokyo, Japan
[10]
Fred Hutchinson Cancer Research Center, Seattle, WA, United States
[11]
Center for International Blood and Marrow Transplant Research, Minneapolis, MN, United States
[12]
Division of Clinical Immunology and Centre for Allogeneic Stem Cell Transplantation, Karolinska
[13]
Haemato-Oncology Research Unit, Division of Molecular Pathology, The Institute of Cancer Research
[14]
Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin
[15]
发布时间
2013-11-20
换一批
换一批
